2022 Annual Results

Analyst Presentation

Stuart Quin (CEO), Richard Jones (CFO) and Marc O'Brien (CIO)

4 April 2022

medica.co.uk

Document classification: Medica Restricted

Agenda

  • 1. FY 2021 highlights

  • 2. Financial review

  • 3. Strategy update & focus on continued growth

    • a. 2021 progress

    • b. Organic growth opportunities & M&A

      • i. UK

      • ii. Ireland

      • iii. US

  • 4. FutureTech Programme update

  • 5. Summary and Outlook

  • 6. Appendix

    • a. Detailed financials

    • b. ESG framework

Document classification:

Highlights

  • Strong recovery in financial performance with revenues up 68% YoY and 33% vs 2019 and operating profits increasing 141% YoY and 7% compared to 2019, the last pre-Covid year.

  • Strong performance from the two acquisitions in Ireland and the US

    • Diversification of service offering and revenue

  • Delivery of first phase of FutureTech: rollout of Sectra PACS in February ahead of time and budget

  • Strong growth in NightHawk in UK with significant renewal of existing contracts together with net new contract wins

300+

750+

175+

1.2m+

Employees

Current network of

Clients

Exams and

worldwide

specialist doctors

worldwide

Reports in

and radiographers

2021

worldwide

medicagroupplc.com

Document classification:

Document classification: Medica Restricted

Financial Highlights

2018 2019 2020 2021

2018 2019 2020 2021

2018 2019 2020 2021

£61.9m

Revenue

£31.4m

Gross Profit

2018 2019 2020 2021

2018 2019 2020 2021

£12.1m

Underlying operating profit*

7.83p

Underlying earnings per share**

50.7%

Gross Profit Margin

*Underlying operating profit is a non-IFRS measure and is calculated as operating profit before exceptional items and one-off costs relating to the Ireland acquisition and associated extension to the debt facility, share based payments, intangible amortisation in respect of acquired assets.

** Underlying earnings per share is a non-IFRS measure and is calculated based underlying operating profits less financing costs and taxation.

medicagroupplc.com

Document classification:

This is an excerpt of the original content. To continue reading it, access the original document here.

Attachments

  • Original Link
  • Original Document
  • Permalink

Disclaimer

Medica Group plc published this content on 05 April 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 05 April 2022 09:37:07 UTC.